Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2005
05/26/2005US20050113359 NMDA (N-methyl-D-aspartate) receptors; eg 1-[4-(4-fluoro-benzyl)-piperidin-1-yl]-1-(6-hydroxy-1H-indole-2-yl)methanone
05/26/2005US20050113358 Enzyme inhibitors for erectile dysfunction and sexual disorders
05/26/2005US20050113357 Cholinergic agents such as 3-[3-(4-methoxypiperidine)-1-yl-propyl]-1H-indole; for therapy of cognitive dysfunction, forgetfulness, confusion, memory loss, attention deficits, deficits in visual perception, depression, pain, sleep disorders, and psychosis
05/26/2005US20050113347 Novel antibacterial compounds: process for their preparation and pharmaceutical compositions containing them
05/26/2005US20050113344 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
05/26/2005US20050113342 Novel imidazole derivatives and their use as pharmaceutical agents
05/26/2005US20050113341 Stent with a disposed traiazine compound such as 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine for inhibiting smooth muscle proliferation; restenosis and atherosclerosis
05/26/2005US20050113295 Carboxamide and amino derivatives and methods of their use
05/26/2005US20050113294 Carboxamide and amino derivatives and methods of their use
05/26/2005US20050112781 4,7-dichlororhodamine dyes labeled polynucleotides
05/26/2005US20050112487 electroconductive supports having layers containing azo compounds, charge transporting substance, acceptors and phenolic compounds, used in laser printer as well as high speed copiers
05/26/2005US20050112407 Organic electroluminescent device
05/26/2005CA2602772A1 Heterocyclic boronic acid compounds
05/26/2005CA2545742A1 Process for the synthesis of imidazoles
05/26/2005CA2545384A1 Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain
05/26/2005CA2545373A1 Novel 1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands
05/26/2005CA2545340A1 Fused heterocyclic compounds
05/26/2005CA2545259A1 Heteroaryl-hydrazone compounds
05/26/2005CA2545258A1 Pyridine compounds
05/26/2005CA2544983A1 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation
05/26/2005CA2544814A1 Non-symmetrical gelling agent
05/26/2005CA2544492A1 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
05/26/2005CA2544186A1 Inhibition of fgfr3 and treatment of multiple myeloma with benzimidazole quinolinones
05/26/2005CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists
05/26/2005CA2543765A1 Methods and compositions for selectin inhibition
05/26/2005CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
05/25/2005EP1533310A1 Isonipecotamides for the treatment of integrin-mediated disorders
05/25/2005EP1533304A1 Amide derivative
05/25/2005EP1533303A1 Substituted Aminosalicylacid Amides ( intermediates )
05/25/2005EP1533294A1 Beta-alanine derivative and use thereof
05/25/2005EP1532980A1 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
05/25/2005EP1532209A2 Charge transport compositions and electronic devices made with such compositions
05/25/2005EP1532158A1 Neutral metallic dendrimer complexes
05/25/2005EP1532138A1 Inhibitors of tyrosine kinases
05/25/2005EP1532137A2 Antimicrobial aza-bicyclic derivates, their compositions and uses
05/25/2005EP1532136A1 Pyridazine derivatives as ligands for gaba receptors
05/25/2005EP1532121A1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives
05/25/2005EP1532120A1 Phenylpyridazine derivatives as ligands for gaba receptors
05/25/2005EP1532118A2 Imidazole compounds for the treatment of hepatitis c virus infections
05/25/2005EP1532117A1 Multi-substituded imidazolines and method of use thereof
05/25/2005EP1532111A1 2,5-disubstituted 3-mercaptopentanoic acid
05/25/2005EP1531822A1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
05/25/2005EP1531821A2 Sulphonylpiperidine derivatives containing an alkenyl or alkynyl moiety for use as matrix metalloproteinase inhibitors
05/25/2005EP1531820A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases
05/25/2005EP1531818A1 Topical treatment of skin diseases
05/25/2005EP1531816A1 Spirocyclic piperidines as mch1 antagonists and uses thereof
05/25/2005EP1531811A2 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
05/25/2005EP1286673B1 Ligands of integrin receptors
05/25/2005EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/25/2005EP1056724B1 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
05/25/2005EP0946511B1 Novel compounds with analgesic effect
05/25/2005DE10349587A1 Benzimidazolylderivate Benzimidazolylderivate
05/25/2005DE10348022A1 Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/25/2005CN1620452A 3, 4-dihydro-1h-isoquinoloin-2-yl-derivatives
05/25/2005CN1620450A Quinazoline(di) ones for invertebrate pest control
05/25/2005CN1620449A Diamide invertebrate pest control agents
05/25/2005CN1620448A Piperidine-2, 6-diones heterocyclically substituted in the 3-position
05/25/2005CN1620435A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
05/25/2005CN1620434A Pyrrolidine-2-ones as factor Xa inhibitors
05/25/2005CN1620433A Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
05/25/2005CN1620424A Compounds for the treatment of inflammatory disorders
05/25/2005CN1620296A Substituted quinazoline derivatives as inhibitors of aurora kinases
05/25/2005CN1620294A Pyrimidine A2b selective antagonist compounds, their synthesis and use
05/25/2005CN1620291A 3-(imidazolyl)-2-alkoxypropanoic acids as TAFIA inhibitors
05/25/2005CN1618828A Triarylsilyl(meth)acryloyl-containing polymers for marine coating compositions
05/25/2005CN1203069C Substituted piperidines, medicaments containing these compounds, and methods for production thereof
05/25/2005CN1203060C Pyridine derivatives, its composition and use
05/24/2005US6897319 Therapeutic drugs for treating central nervous system disorders
05/24/2005US6897318 Process for making substituted pyrazoles
05/24/2005US6897317 For therapy of arteriosclerosis and dyslipidaemias
05/24/2005US6897315 Method for producing 8-methoxy-quinolinecarboxylic acids
05/24/2005US6897314 Process for preparing imidazoquinolinamines
05/24/2005US6897309 One pot process; using base; then hydroxylation
05/24/2005US6897234 Asthma therapy; antiallergens; antiinflammatory agents
05/24/2005US6897231 Jun n- terminal kinase inhibitors such as 3-(4-methoxyphenyl)-1H-indazole
05/24/2005US6897228 Pyridoxine and pyridoxal analogues: new uses
05/24/2005US6897227 Prodrugs of proton pump inhibitors
05/24/2005US6897226 NK-1 receptor active amine oxide prodrugs
05/24/2005US6897220 Antiproliferative agents
05/24/2005US6897219 Central nervous system diosrders; analgesics; antiinflammatory agents
05/24/2005US6897214 Quinazoline derivatives
05/24/2005US6897213 Heterocycles as cholecystokinin (CCK) ligands
05/24/2005US6897210 Anticancer agents; antiarthritic agents
05/24/2005US6897208 Protein kinase inhibitors
05/24/2005US6896891 Non-systemic control of parasites
05/24/2005CA2157792C N-(3-piperidinyl-carbonyl)-beta-alanine derivatives as paf antagonists
05/19/2005WO2005044988A2 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
05/19/2005WO2005044817A1 Modulators of cellular adhesion
05/19/2005WO2005044815A1 Method for the synthesis of pantoprazole and intermediates
05/19/2005WO2005044814A1 BENZO [b][1,4] DIOXEPINE DERIVATIVES
05/19/2005WO2005044807A2 Benzoimidazole compounds
05/19/2005WO2005044797A1 Allosteric modulators of metabotropic glutamate receptors
05/19/2005WO2005044795A1 Process for the preparation of ccr-2 antagonist
05/19/2005WO2005044268A1 Preparation of pharmaceutical salts of [1, 4] - bipiperidine
05/19/2005WO2005044260A1 Use of crth2 antagonist compounds in therapy
05/19/2005WO2005044195A2 Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
05/19/2005WO2005044192A2 Triazole compounds and uses related thereto
05/19/2005WO2005035500A3 Therapeutic agents useful for treating pain
05/19/2005WO2005028436A3 Thalidomide analogs as tnf-alpha modulators
05/19/2005WO2004037811A8 Selected cgrp antagonists, method for production and use thereof as medicament
1 ... 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 ... 1080